{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:03:50Z","timestamp":1785452630197,"version":"3.56.0"},"reference-count":47,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,8,15]]},"DOI":"10.2169\/internalmedicine.1631-23","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:12:41Z","timestamp":1692051161000},"page":"2381-2387","source":"Crossref","is-referenced-by-count":4,"title":["Acute Interstitial Nephritis with Glomerular Capillary IgA Deposition Following SARS-CoV-2 mRNA Vaccination"],"prefix":"10.2169","volume":"62","author":[{"given":"Erika","family":"Hishida","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuho","family":"Oe","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimi","family":"Imai","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Yoshizawa","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Nakaya","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Kawata","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Akimoto","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nagata","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 383: 2603-2615, 2020.","DOI":"10.1056\/NEJMoa2034577"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Baden LR, El Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384: 403-416, 2021.","DOI":"10.1056\/NEJMoa2035389"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Klomjit N, Alexander MP, Fervenza FC, et al. COVID-19 vaccination and glomerulonephritis. Kidney Int Rep 6: 2969-2978, 2021.","DOI":"10.1016\/j.ekir.2021.09.008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bomback AS, Kudose S, D&apos;Agati VD. <i>De novo<\/i> and relapsing glomerular diseases after COVID-19 vaccination: what do we know so far? Am J Kidney Dis 78: 477-480, 2021.","DOI":"10.1053\/j.ajkd.2021.06.004"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sacker A, Kung V, Andeen N. Anti-GBM nephritis with mesangial IgA deposits after SARS-CoV-2 mRNA vaccination. Kidney Int 100: 471-472, 2021.","DOI":"10.1016\/j.kint.2021.06.006"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shakoor MT, Birkenbach MP, Lynch M. ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis 78: 611-613, 2021.","DOI":"10.1053\/j.ajkd.2021.06.016"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Leclerc S, Royal V, Lamarche C, Laurin LP. Minimal change disease with severe acute kidney injury following the Oxford-AstraZeneca COVID-19 vaccine: a case report. Am J Kidney Dis 78: 607-610, 2021.","DOI":"10.1053\/j.ajkd.2021.06.008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Izzedine H, Bonilla M, Jhaveri KD. Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial? Nephrol Dial Transplant 36: 1565-1569, 2021.","DOI":"10.1093\/ndt\/gfab215"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Komaba H, Wada T, Fukagawa M. Relapse of minimal change disease following the Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis 78: 469-470, 2021.","DOI":"10.1053\/j.ajkd.2021.05.006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Zavala-Miranda MF, Gonz\u00e1lez-Ibarra SG, P\u00e9rez-Arias AA, Uribe-Uribe NO, Mejia-Vilet JM. New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination. Kidney Int 100: 1340-1341, 2021.","DOI":"10.1016\/j.kint.2021.09.009"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gupta RK, Ellis BK. Concurrent antiglomerular basement membrane nephritis and antineutrophil cytoplasmic autoantibody-mediated glomerulonephritis after second dose of SARS-CoV-2 mRNA vaccination. Kidney Int Rep 7: 127-128, 2022.","DOI":"10.1016\/j.ekir.2021.10.020"},{"key":"12","unstructured":"12. Dheir H, Sipahi S, Cakar G, Yaylaci S, Hacibekiroglu T, Karabay O. Acute tubulointerstitial nephritis after COVID-19 m-RNA BNT162b2 vaccine. Eur Rev Med Pharmacol Sci 25: 6171-6173, 2021."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mira FS, Carvalho JC, de Almeida PA, et al. A case of acute interstitial nephritis after two doses of the BNT162b2 SARS-CoV-2 vaccine. Int J Nephrol Renovasc Dis 14: 421, 2021.","DOI":"10.2147\/IJNRD.S345898"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Unver S, Haholu A, Yildirim S. Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine. Clin Kidney J 14: 2608-2611, 2021.","DOI":"10.1093\/ckj\/sfab155"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Storrar J, Kudose S, Woywodt A. Have we missed AINything? Acute interstitial nephritis in SARS-CoV-2 infection and vaccination. Clin Kidney J 15: 1643-1652, 2022.","DOI":"10.1093\/ckj\/sfac147"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. de la Flor Merino JC, Gravalos TL, Alonso-Ria\u00f1o M, et al. A case of acute interstitial nephritis following the Pfizer-BioNTech COVID-19 vaccine. Nefrologia 42: 617-620, 2022 (in Spanish).","DOI":"10.1016\/j.nefroe.2021.05.007"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Jongvilaikasem P, Rianthavorn P. Minimal change disease and acute interstitial nephritis following SARS-CoV-2 BNT162b2 vaccination. Pediatric Nephrology 37: 1419-1421, 2022.","DOI":"10.1007\/s00467-022-05470-z"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Fenoglio R, Lalloni S, Marchisio M, et al. New onset biopsy-proven nephropathies after COVID vaccination. Am J Nephrol 53: 325-330, 2022.","DOI":"10.1159\/000523962"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Liew SK, Nair B, So B, Ponnusamy A, Bow A, Woywodt A. Acute interstitial nephritis following SARS-CoV-2 virus vaccination. Clin Nephrol 97: 242-245, 2022.","DOI":"10.5414\/CN110753"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rieckmann S, Seibert FS, Hogeweg M, et al. Acute interstitial nephritis after vaccination with BNT162b2. J Nephrol 35: 779-782, 2022.","DOI":"10.1007\/s40620-022-01275-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wu HH, Li JW, Bow A, Woywodt A, Ponnusamy A. Acute interstitial nephritis following SARS-CoV-2 vaccination. Clin Kidney J 15: 576-581, 2022.","DOI":"10.1093\/ckj\/sfab253"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Schaubschlager T, Rajora N, Diep S, et al. <i>De novo<\/i> or recurrent glomerulonephritis and acute tubulointerstitial nephritis after COVID-19 vaccination: a report of six cases from a single center. Clin Nephrol 97: 289-297, 2022.","DOI":"10.5414\/CN110794"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Choi JH, Kang KS, Han KH. Two adolescent cases of acute tubulointerstitial nephritis after second dose of COVID-19 mRNA vaccine. Hum Vaccin Immunother 18: 2059308, 2022.","DOI":"10.1080\/21645515.2022.2059308"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Czerlau C, Bocchi F, Saganas C, Vogt B. Acute interstitial nephritis after messenger RNA-based vaccination. Clin Kidney J 15: 174-176, 2022.","DOI":"10.1093\/ckj\/sfab180"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tan FS, Kabir ME, Bhandari S. Acute interstitial nephritis after COVID-19 vaccination. BMJ Case Rep CP 15: e246841, 2022.","DOI":"10.1136\/bcr-2021-246841"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Schnuelle P, Schwab C, Waldherr R, Zeier M, Bischofs C. Biopsy-proven acute interstitial nephritis after SARS-CoV-2 mRNA vaccination - adverse vaccine side effect or unrelated complication from self-medication? Lessons for the clinical nephrologist. J Nephrol 36: 631-633, 2022.","DOI":"10.1007\/s40620-022-01519-2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Masset C, Kervella D, Kandel-Aznar C, Fantou A, Blancho G, Hamidou M. Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine. Kidney Int 100: 465, 2021.","DOI":"10.1016\/j.kint.2021.06.002"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Praga M, Gonzalez E. Acute interstitial nephritis. Kidney Int 77: 956-961, 2010.","DOI":"10.1038\/ki.2010.89"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hishida E, Masuda T, Akimoto T, et al. Renal failure found during the follow-up of sarcoidosis: the relevance of a delay in the diagnosis of concurrent hypercalcemia. Intern Med 55: 1893-1898, 2016.","DOI":"10.2169\/internalmedicine.55.6194"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hishida E, Kobayashi T, Ono Y, et al. Tubulointerstitial nephritis in antineutrophil cytoplasmic antibody-associated vasculitis with monoclonal gammopathy. CEN Case Rep 11: 36-42, 2022.","DOI":"10.1007\/s13730-021-00620-y"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Jansen J, Reimer KC, Nagai JS, et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell 29: 217-231 e218, 2022.","DOI":"10.1016\/j.stem.2021.12.010"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Fukao Y, Nagasawa H, Nihei Y, et al. COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine. Clin Exp Nephrol 25: 1240-1246, 2021.","DOI":"10.1007\/s10157-021-02101-z"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, et al. COVID-19 and kidney injury: pathophysiology and molecular mechanisms. Rev Med Virol 31: e2176, 2021.","DOI":"10.1002\/rmv.2176"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Yokote S, Ueda H, Shimizu A, et al. IgA nephropathy with glomerular capillary IgA deposition following SARS-CoV-2 mRNA vaccination: a report of three cases. CEN Case Rep 11: 499-505, 2022.","DOI":"10.1007\/s13730-022-00707-0"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Border WA, Baehler RW, Bhathena D, Glassock RJ. IgA antibasement membrane nephritis with pulmonary hemorrhage. Ann Intern Med 91: 21-25, 1979.","DOI":"10.7326\/0003-4819-91-1-21"},{"key":"36","unstructured":"36. Nakano H, Suzuki A, Tojima H, et al. [A case of Goodpasture&apos;s syndrome with IgA antibasement membrane antibody]. Nihon Kyobu Shikkan Gakkai Zasshi 28: 634-638, 1990 (in Japanese)."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. de Caestecker MP, Hall CL, MacIver AG. Atypical antiglomerular basement membrane disease associated with thin membrane nephropathy. Nephrol Dial Transplant 5: 909-913, 1990.","DOI":"10.1093\/ndt\/5.11.909"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Gris P, Pirson Y, Hamels J, Vaerman JP, Quoidbach A, Demol H. Antiglomerular basement membrane nephritis induced by IgA1 antibodies. Nephron 58: 418-424, 1991.","DOI":"10.1159\/000186473"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Fervenza FC, Terreros D, Boutaud A, et al. Recurrent Goodpasture&apos;s disease due to a monoclonal IgA-kappa circulating antibody. Am J Kidney Dis 34: 549-555, 1999.","DOI":"10.1016\/S0272-6386(99)70084-3"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Maes B, Vanwalleghem J, Kuypers D, Van Damme B, Waer M, Vanrenterghem Y. IgA antiglomerular basement membrane disease associated with bronchial carcinoma and monoclonal gammopathy. Am J Kidney Dis 33: E3, 1999.","DOI":"10.1016\/S0272-6386(99)70324-0"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Carreras L, Poveda R, Bas J, Mestre M, Rama I, Carrera M. Goodpasture syndrome during the course of a Sch\u00f6nlein-Henoch purpura. Am J Kidney Dis 39: E21, 2002.","DOI":"10.1053\/ajkd.2002.32799"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Shaer AJ, Stewart LR, Cheek DE, Hurray D, Self SE. IgA antiglomerular basement membrane nephritis associated with Crohn&apos;s disease: a case report and review of glomerulonephritis in inflammatory bowel disease. Am J Kidney Dis 41: 1097-1109, 2003.","DOI":"10.1016\/S0272-6386(03)00208-7"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Borza DB, Chedid MF, Colon S, Lager DJ, Leung N, Fervenza FC. Recurrent Goodpasture&apos;s disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1\/alpha2 chains of type IV collagen. Am J Kidney Dis 45: 397-406, 2005.","DOI":"10.1053\/j.ajkd.2004.09.029"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Ke CL, Wen YK, Chen ML. IgA variant of anti-glomerular basement membrane glomerulonephritis associated with pulmonary hemorrhage and microangiopathic hemolytic anemia. Ren Fail 34: 657-660, 2012.","DOI":"10.3109\/0886022X.2012.664807"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Moulis G, Huart A, Guitard J, Fortenfant F, Chauveau D. IgA-mediated anti-glomerular basement membrane disease: an uncommon mechanism of Goodpasture&apos;s syndrome. Clin Kidney J 5: 545-548, 2012.","DOI":"10.1093\/ckj\/sfs087"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Antonelou M, Henderson SR, Bhangal G, et al. Binding truths: atypical anti-glomerular basement membrane disease mediated by IgA anti-glomerular basement membrane antibodies targeting the \u03b11 chain of type IV collagen. Kidney Int Rep 4: 163-167, 2019.","DOI":"10.1016\/j.ekir.2018.08.005"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Nasr SH, D&apos;Agati VD. IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease. Nephron Clin Pract 119: c18-c26, 2011.","DOI":"10.1159\/000324180"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/16\/62_1631-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T03:22:35Z","timestamp":1692415355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/16\/62_1631-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":47,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1631-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"article-number":"1631-23"}}